Equine NSAID Dosage Calculator
Weight-calibrated clinical dosing for Banamine, Bute, and Equioxx. Accurate syringe ring calibrations, USEF/FEI withdrawal windows, and black-box safety warnings to protect your horse from fatal myonecrosis and right dorsal colitis.
Equine NSAID & Dosage Calculator
Weight-calibrated therapeutic dosing for Banamine (Flunixin), Bute (Phenylbutazone), and Equioxx (Firocoxib) with AAEP safety directives.
CRITICAL SAFETY DIRECTIVE: Administer Banamine ONLY via Oral Paste or Intravenous (IV) injection. Never give intramuscularly (IM), as it carries a high mortality rate from Clostridial myositis.
Visceral Pain (Colic), Endotoxemia & Acute Musculoskeletal Inflammation
- NEVER administer Intramuscularly (IM) due to fatal Clostridial myonecrosis / gas gangrene risk
- Do not combine with phenylbutazone or firocoxib (concurrent NSAID stacking induces acute renal papillary necrosis)
- Withhold in dehydrated, hypovolemic, or hemodynamically shocked horses to protect renal perfusion
Safe Equine Anti-Inflammatory Stewardship
Non-steroidal anti-inflammatory drugs (NSAIDs) represent the cornerstone of equine pain relief, anti-pyresis, and anti-endotoxemia management. However, because horses metabolize NSAIDs through hepatic glucuronidation and renal excretion, therapeutic windows are narrow. Administering NSAIDs without weighing your horse or understanding pharmacological contraindications creates severe, sometimes fatal complications.
Potent inhibitor of visceral smooth muscle pain and endotoxin-induced prostanoids. Rapid onset within 1–2 hours. Administer orally or IV only.
Superior affinity for musculoskeletal inflammation, laminitis, and navicular syndrome. Requires monitoring to avoid gastric ulceration and right dorsal colitis.
Selective COX-2 inhibitor sparing stomach and kidney COX-1 enzymes. The preferred long-term option for senior horses and competitive sport horses with degenerative joint disease.
Veterinary Pharmacology Frequently Asked Questions
Why must Banamine (flunixin meglumine) never be administered intramuscularly (IM)?
Administering flunixin meglumine intramuscularly introduces significant risks of Clostridial myonecrosis (gas gangrene or "blackleg"). Spores of Clostridium perfringens or septicum normally dormant in muscle tissue germinate in the presence of focal tissue necrosis and ischemia induced by acidic flunixin solution. Clostridial myositis exhibits rapid progression, severe toxemia, and a 40%–60% mortality rate requiring extensive surgical muscle fenestration and hyperbaric oxygen therapy. Flunixin should be given strictly via oral paste or slow intravenous (IV) injection.
What is the danger of combining Phenylbutazone (Bute) and Banamine simultaneously?
Concurrent administration of multiple non-steroidal anti-inflammatory drugs ("NSAID stacking") severely inhibits cyclooxygenase (COX-1 and COX-2) enzymes throughout the equine body. This halts protective prostaglandin E2 and prostacyclin synthesis in the gastric mucosa and kidneys. Combined therapy multiplies the incidence of right dorsal ulcerative colitis (severe protein-losing enteropathy) and acute renal papillary necrosis, particularly if the horse is dehydrated or under competitive stress.
How does Firocoxib (Equioxx) differ from traditional non-selective NSAIDs?
Firocoxib is a second-generation COX-2 selective NSAID. It preferentially targets the inducible cyclooxygenase-2 enzyme responsible for inflammatory prostaglandins while sparing the constitutive COX-1 enzyme that maintains gastric mucosal integrity and physiological renal blood flow. As a result, firocoxib exhibits significantly lower gastrointestinal ulceration risk during extended chronic osteoarthritis management, though it still requires adherence to labeled dosages.
What are the USEF and FEI competition withdrawal guidelines for NSAIDs?
Under USEF Guidelines & Rules for Drugs and Medications, only one systemic NSAID may be detected in post-competition plasma samples. The standard approximate detection window for flunixin meglumine is 48 hours prior to competing (with a maximum single therapeutic dose not exceeding 0.5 mg/lb), and 72 hours for phenylbutazone (not exceeding 2.0 mg/lb). The FEI maintains a stricter Controlled Medication framework requiring adherence to their published Detection Times or Veterinary Clearance Forms.